-
-
-
-
-
-
-
Teva lawsuit against Eli Lilly over Forteo revived by appeals court
-
-
-
-
-
-
-
FDA greenlights continued generic access for Micardis
-
-
-
-
-
-
-
Jefferies on Teva Pharma (TEVA): 'early, but investors should pay attention'
-
-
-
-
-
-
-
FDA accepts Teva's drug application for monthly schizophrenia treatment
-
-
-
-
-
-
-
Teva Pharma (TEVA) PT Raised to $38 at Truist Securities
-
-
-
-
-
-
-
Royalty Pharma provides up to $500 million for TEVA vitiligo drug
-
-
-
-
-
-
-
Teva submits FDA application for monthly schizophrenia injection
-
451,537 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

